SBC Medical Group (NASDAQ:SBC) reported first-quarter 2026 revenue of $43 million, down 9% from a year earlier, as management said prior fee structure revisions continued to weigh on reported results even as underlying clinic activity improved.
Yuya Yoshida, chief financial officer of SBC Medical Group Holdings, said the revenue decline was primarily tied to fee structure revisions that took effect in April of last year. Those changes reduced franchising revenue by $6.2 million and management services revenue by $2.4 million, for a total negative impact of $8.7 million. Procurement revenue and rental services revenue also declined year over year, while management services revenue was partly offset by an increase in point revenue.
